Proceedings Of The 55Th Annual General Meeting
Proceedings of the 55th Annual General Meeting28-07-2018
28-07-2018
Outcome of Board Meeting
1. Unaudited Financial Results for the quarter ended June 30, 2018 2. Allotment of 6075 under the ESOP scheme 200828-07-2018
Statement Of Investor Complaints For The Quarter Ended June 2018 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- NEEMA THAKOREDesignation :- Company Secretary and Compliance Officer13-07-2018
Shareholding for the Period Ended June 30, 2018
Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here13-07-2018
Board Meeting On July 28, 2018
To consider and approve the unaudited financial results for the period ended Jun 30, 2018 Further, in terms of the Company's Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in shares of the Company will be closed from July 12, 2018 for Designated Persons,...12-07-2018
Notice Of AGM, Record Date & Dividend Payment Date And News Paper Advertisement
The 55th Annual General Meeting (AGM) of the Members of Unichem Laboratories Limited will be held on Saturday, July 28, 2018 at 3.00 p.m. at Rama Watumull Auditorium, Kishinchand Chellaram College (K. C. College), Dinshaw Wachha Road, Churchgate, Mumbai 400 020. Please find enclosed herewith a copy of the 55th AGM notice. The Annual Report for the year ended March 31, 2018 alongwith the Notice is dispatched to the Members of the Company...04-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release pertaining to receipt of ANDA approval from USFDA for Unichem's Montelukast Chewable Tablets, 4 mg and 5 mg04-07-2018
Clarification Regarding Intimation Dated June 20, 2018, Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Clarification regarding Intimation dated June 20, 2018, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-06-2018
Will patent pact lift Unichem Labs?
Unichem Laboratories has entered into a settlement pact with pharma major Eli Lilly & Company and ICOS Corporation for resolving their patent lit20-06-2018